STOCK TITAN

[Form 4] USANA Health Sciences Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

USANA Health Sciences (USNA) – Form 4 filing

On 24-Jul-2025, CEO & President Jim Brown converted 2,190 previously granted restricted stock units (code “M”) into an equal number of common shares. To satisfy withholding taxes, 972 of those shares were automatically surrendered to the issuer at $32.09 per share (code “F”). The net effect is an increase of 1,218 directly held shares, bringing Brown’s direct common-stock ownership to 16,934. He also retains 160,878 unvested/derivative RSUs that will convert into common shares as they vest. No open-market purchases or sales occurred; all transactions were internal equity-compensation settlements. The filing does not disclose any broader corporate developments.

USANA Health Sciences (USNA) – Deposito Form 4

Il 24 luglio 2025, il CEO e Presidente Jim Brown ha convertito 2.190 unità azionarie vincolate precedentemente assegnate (codice “M”) in un numero uguale di azioni ordinarie. Per coprire le imposte di ritenuta, 972 di queste azioni sono state automaticamente restituite all'emittente al prezzo di $32,09 per azione (codice “F”). L'effetto netto è un aumento di 1.218 azioni detenute direttamente, portando la proprietà diretta di azioni ordinarie di Brown a 16.934. Mantiene inoltre 160.878 RSU non maturate/derivate che si convertiranno in azioni ordinarie al momento della maturazione. Non sono stati effettuati acquisti o vendite sul mercato aperto; tutte le transazioni sono state regolamenti interni di compensazione azionaria. Il deposito non rivela sviluppi aziendali più ampi.

USANA Health Sciences (USNA) – Presentación Formulario 4

El 24 de julio de 2025, el CEO y Presidente Jim Brown convirtió 2,190 unidades de acciones restringidas previamente otorgadas (código “M”) en un número igual de acciones comunes. Para cubrir los impuestos retenidos, 972 de esas acciones fueron automáticamente entregadas al emisor a $32.09 por acción (código “F”). El efecto neto es un aumento de 1,218 acciones en propiedad directa, elevando la tenencia directa de acciones comunes de Brown a 16,934. Además, conserva 160,878 RSU no adquiridas/derivadas que se convertirán en acciones comunes a medida que vayan madurando. No se realizaron compras ni ventas en el mercado abierto; todas las transacciones fueron liquidaciones internas de compensación accionaria. La presentación no revela ningún desarrollo corporativo más amplio.

USANA Health Sciences (USNA) – Form 4 제출

2025년 7월 24일, CEO 겸 사장 Jim Brown이 이전에 부여된 제한 주식 단위(RSU) 2,190개(코드 “M”)를 동일한 수의 보통주로 전환했습니다. 원천징수세를 충당하기 위해 972주가 주당 $32.09(코드 “F”)에 발행사에 자동으로 반환되었습니다. 순효과는 직접 보유 주식이 1,218주 증가하여 Brown의 직접 보통주 보유량이 16,934주가 되었습니다. 또한 아직 취득하지 않은/파생된 RSU 160,878주를 보유하고 있으며, 이들은 취득 시 보통주로 전환됩니다. 공개 시장에서의 매매는 없었으며, 모든 거래는 내부 주식 보상 정산이었습니다. 이번 제출서류에서는 더 넓은 기업 관련 발전 사항은 공개되지 않았습니다.

USANA Health Sciences (USNA) – Dépôt du Formulaire 4

Le 24 juillet 2025, le PDG et Président Jim Brown a converti 2 190 unités d’actions restreintes précédemment attribuées (code « M ») en un nombre égal d’actions ordinaires. Pour couvrir les impôts à la source, 972 de ces actions ont été automatiquement remises à l’émetteur au prix de 32,09 $ par action (code « F »). L’effet net est une augmentation de 1 218 actions détenues directement, portant la détention directe d’actions ordinaires de Brown à 16 934. Il conserve également 160 878 RSU non acquises/dérivées qui seront converties en actions ordinaires à mesure de leur acquisition. Aucune transaction sur le marché ouvert n’a eu lieu ; toutes les opérations étaient des règlements internes liés à la rémunération en actions. Le dépôt ne révèle aucun développement corporatif plus large.

USANA Health Sciences (USNA) – Form 4 Einreichung

Am 24. Juli 2025 wandelte CEO und Präsident Jim Brown 2.190 zuvor gewährte Restricted Stock Units (Code „M“) in eine gleiche Anzahl von Stammaktien um. Zur Begleichung der Quellensteuer wurden 972 dieser Aktien automatisch zum Preis von $32,09 pro Aktie (Code „F“) an den Emittenten zurückgegeben. Der Nettoeffekt ist eine Erhöhung von 1.218 direkt gehaltenen Aktien, womit Browns direkter Stammaktienbesitz auf 16.934 steigt. Er hält außerdem 160.878 nicht fällige/abgeleitete RSUs, die bei Fälligkeit in Stammaktien umgewandelt werden. Es fanden keine Käufe oder Verkäufe am offenen Markt statt; alle Transaktionen waren interne Abrechnungen von Aktienvergütungen. Die Einreichung enthält keine Hinweise auf weitergehende unternehmerische Entwicklungen.

Positive
  • CEO Jim Brown increased his direct ownership by 1,218 shares, indicating continued alignment with shareholders.
  • A substantial pool of 160,878 RSUs remains, tying executive compensation to future share performance.
Negative
  • 972 shares were immediately surrendered for tax withholding, reducing the net share increase.

Insights

TL;DR: Routine RSU vesting; CEO nets 1,218 shares, overall impact neutral.

The transaction reflects a scheduled vesting event rather than discretionary buying or selling. Brown’s gross conversion of 2,190 RSUs and tax withholding of 972 shares is standard practice. His post-transaction holding of 16,934 shares remains small relative to the 160,878 RSUs still outstanding, implying most of his equity upside is tied to future company performance. Because no open-market activity or new grants are involved, dilution and market-signal effects are minimal. From an investor viewpoint the filing is not materially impactful but confirms ongoing insider alignment via equity retention.

USANA Health Sciences (USNA) – Deposito Form 4

Il 24 luglio 2025, il CEO e Presidente Jim Brown ha convertito 2.190 unità azionarie vincolate precedentemente assegnate (codice “M”) in un numero uguale di azioni ordinarie. Per coprire le imposte di ritenuta, 972 di queste azioni sono state automaticamente restituite all'emittente al prezzo di $32,09 per azione (codice “F”). L'effetto netto è un aumento di 1.218 azioni detenute direttamente, portando la proprietà diretta di azioni ordinarie di Brown a 16.934. Mantiene inoltre 160.878 RSU non maturate/derivate che si convertiranno in azioni ordinarie al momento della maturazione. Non sono stati effettuati acquisti o vendite sul mercato aperto; tutte le transazioni sono state regolamenti interni di compensazione azionaria. Il deposito non rivela sviluppi aziendali più ampi.

USANA Health Sciences (USNA) – Presentación Formulario 4

El 24 de julio de 2025, el CEO y Presidente Jim Brown convirtió 2,190 unidades de acciones restringidas previamente otorgadas (código “M”) en un número igual de acciones comunes. Para cubrir los impuestos retenidos, 972 de esas acciones fueron automáticamente entregadas al emisor a $32.09 por acción (código “F”). El efecto neto es un aumento de 1,218 acciones en propiedad directa, elevando la tenencia directa de acciones comunes de Brown a 16,934. Además, conserva 160,878 RSU no adquiridas/derivadas que se convertirán en acciones comunes a medida que vayan madurando. No se realizaron compras ni ventas en el mercado abierto; todas las transacciones fueron liquidaciones internas de compensación accionaria. La presentación no revela ningún desarrollo corporativo más amplio.

USANA Health Sciences (USNA) – Form 4 제출

2025년 7월 24일, CEO 겸 사장 Jim Brown이 이전에 부여된 제한 주식 단위(RSU) 2,190개(코드 “M”)를 동일한 수의 보통주로 전환했습니다. 원천징수세를 충당하기 위해 972주가 주당 $32.09(코드 “F”)에 발행사에 자동으로 반환되었습니다. 순효과는 직접 보유 주식이 1,218주 증가하여 Brown의 직접 보통주 보유량이 16,934주가 되었습니다. 또한 아직 취득하지 않은/파생된 RSU 160,878주를 보유하고 있으며, 이들은 취득 시 보통주로 전환됩니다. 공개 시장에서의 매매는 없었으며, 모든 거래는 내부 주식 보상 정산이었습니다. 이번 제출서류에서는 더 넓은 기업 관련 발전 사항은 공개되지 않았습니다.

USANA Health Sciences (USNA) – Dépôt du Formulaire 4

Le 24 juillet 2025, le PDG et Président Jim Brown a converti 2 190 unités d’actions restreintes précédemment attribuées (code « M ») en un nombre égal d’actions ordinaires. Pour couvrir les impôts à la source, 972 de ces actions ont été automatiquement remises à l’émetteur au prix de 32,09 $ par action (code « F »). L’effet net est une augmentation de 1 218 actions détenues directement, portant la détention directe d’actions ordinaires de Brown à 16 934. Il conserve également 160 878 RSU non acquises/dérivées qui seront converties en actions ordinaires à mesure de leur acquisition. Aucune transaction sur le marché ouvert n’a eu lieu ; toutes les opérations étaient des règlements internes liés à la rémunération en actions. Le dépôt ne révèle aucun développement corporatif plus large.

USANA Health Sciences (USNA) – Form 4 Einreichung

Am 24. Juli 2025 wandelte CEO und Präsident Jim Brown 2.190 zuvor gewährte Restricted Stock Units (Code „M“) in eine gleiche Anzahl von Stammaktien um. Zur Begleichung der Quellensteuer wurden 972 dieser Aktien automatisch zum Preis von $32,09 pro Aktie (Code „F“) an den Emittenten zurückgegeben. Der Nettoeffekt ist eine Erhöhung von 1.218 direkt gehaltenen Aktien, womit Browns direkter Stammaktienbesitz auf 16.934 steigt. Er hält außerdem 160.878 nicht fällige/abgeleitete RSUs, die bei Fälligkeit in Stammaktien umgewandelt werden. Es fanden keine Käufe oder Verkäufe am offenen Markt statt; alle Transaktionen waren interne Abrechnungen von Aktienvergütungen. Die Einreichung enthält keine Hinweise auf weitergehende unternehmerische Entwicklungen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Brown Jim

(Last) (First) (Middle)
3838 WEST PARKWAY BLVD.

(Street)
SALT LAKE CITY UT 84120

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CEO & PRESIDENT
3. Date of Earliest Transaction (Month/Day/Year)
07/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/24/2025 M 2,190 A (1) 17,906 D
Common Stock 07/24/2025 F 972 D $32.09 16,934 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 07/24/2025 M 2,190 (2) (2) Common Stock 2,190 $0 160,878 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. Restricted Stock Units vest 25% on the Anniversary of July 24th, 2023.
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact 07/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did USNA file on Form 4 dated 07/24/2025?

CEO Jim Brown converted 2,190 RSUs into common shares and withheld 972 shares for taxes.

How many USNA shares does Jim Brown own after the transaction?

16,934 common shares held directly.

At what price were the withheld USNA shares valued?

The 972 withheld shares were valued at $32.09 each.

How many restricted stock units does the CEO still hold?

Brown retains 160,878 RSUs, convertible into the same number of USNA shares upon vesting.

Was this an open-market purchase or sale of USNA stock?

No; the filing shows internal RSU conversion and tax withholding, not market transactions.
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

585.51M
10.77M
42.19%
59.03%
4.45%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY